 Makoto Miyazaki
Concepts (561)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stearoyl-CoA Desaturase | 42 | 2015 | 65 | 4.690 |
Why?
| | Vascular Calcification | 9 | 2022 | 108 | 4.110 |
Why?
| | Renal Insufficiency, Chronic | 9 | 2024 | 617 | 2.350 |
Why?
| | Endoplasmic Reticulum | 6 | 2025 | 265 | 1.800 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 9 | 2018 | 220 | 1.720 |
Why?
| | Activating Transcription Factor 4 | 5 | 2021 | 20 | 1.660 |
Why?
| | Atherosclerosis | 8 | 2021 | 415 | 1.640 |
Why?
| | Transcription Factor CHOP | 4 | 2018 | 31 | 1.550 |
Why?
| | Bile Acids and Salts | 3 | 2018 | 200 | 1.410 |
Why?
| | Autophagy | 6 | 2025 | 284 | 1.390 |
Why?
| | Fatty Acids | 19 | 2018 | 443 | 1.240 |
Why?
| | Liver | 21 | 2019 | 1943 | 1.190 |
Why?
| | Endoplasmic Reticulum Stress | 4 | 2021 | 110 | 1.170 |
Why?
| | Calcinosis | 4 | 2014 | 235 | 1.050 |
Why?
| | Membrane Proteins | 4 | 2025 | 1164 | 1.020 |
Why?
| | Mice | 73 | 2025 | 17787 | 1.010 |
Why?
| | Lipids | 12 | 2022 | 672 | 0.990 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2018 | 220 | 0.890 |
Why?
| | Adverse Drug Reaction Reporting Systems | 3 | 2021 | 77 | 0.870 |
Why?
| | Animals | 82 | 2025 | 36940 | 0.800 |
Why?
| | Deoxycholic Acid | 3 | 2022 | 14 | 0.780 |
Why?
| | Kidney | 10 | 2025 | 1468 | 0.770 |
Why?
| | Hyperphosphatemia | 1 | 2022 | 15 | 0.760 |
Why?
| | Stearic Acids | 2 | 2012 | 15 | 0.750 |
Why?
| | Leptin | 9 | 2010 | 236 | 0.740 |
Why?
| | Mice, Knockout | 29 | 2025 | 3015 | 0.730 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2025 | 455 | 0.680 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2018 | 261 | 0.660 |
Why?
| | Vascular Diseases | 2 | 2014 | 243 | 0.630 |
Why?
| | Starvation | 1 | 2019 | 22 | 0.620 |
Why?
| | Autistic Disorder | 1 | 2022 | 204 | 0.620 |
Why?
| | Isoenzymes | 6 | 2006 | 304 | 0.610 |
Why?
| | Cyclin T | 1 | 2018 | 2 | 0.600 |
Why?
| | Cyclin-Dependent Kinase 9 | 1 | 2018 | 10 | 0.600 |
Why?
| | Vascular Stiffness | 1 | 2024 | 494 | 0.600 |
Why?
| | Lipid Metabolism | 15 | 2018 | 518 | 0.600 |
Why?
| | Mice, Inbred C57BL | 25 | 2025 | 5757 | 0.550 |
Why?
| | Apolipoproteins E | 4 | 2014 | 83 | 0.530 |
Why?
| | Kidney Diseases | 4 | 2019 | 408 | 0.530 |
Why?
| | Coronary Vessels | 2 | 2022 | 248 | 0.520 |
Why?
| | eIF-2 Kinase | 2 | 2013 | 31 | 0.510 |
Why?
| | Autism Spectrum Disorder | 1 | 2022 | 395 | 0.510 |
Why?
| | Cholesterol | 8 | 2016 | 410 | 0.510 |
Why?
| | Lipogenesis | 4 | 2012 | 61 | 0.500 |
Why?
| | Vaccines | 1 | 2021 | 406 | 0.480 |
Why?
| | Phosphatidylethanolamines | 1 | 2015 | 77 | 0.470 |
Why?
| | Coronary Artery Disease | 2 | 2022 | 698 | 0.470 |
Why?
| | Triglycerides | 11 | 2014 | 524 | 0.460 |
Why?
| | Fatty Acid Desaturases | 2 | 2006 | 32 | 0.440 |
Why?
| | Osteogenesis | 4 | 2021 | 188 | 0.430 |
Why?
| | Polycystic Kidney Diseases | 2 | 2025 | 76 | 0.420 |
Why?
| | Signal Transduction | 15 | 2024 | 5079 | 0.420 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 5 | 2020 | 37 | 0.420 |
Why?
| | Dietary Fats | 5 | 2007 | 304 | 0.400 |
Why?
| | Disease Models, Animal | 14 | 2025 | 4295 | 0.400 |
Why?
| | Blood Vessels | 2 | 2011 | 187 | 0.400 |
Why?
| | Metabolomics | 1 | 2018 | 678 | 0.390 |
Why?
| | TOR Serine-Threonine Kinases | 3 | 2025 | 412 | 0.380 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 3 | 2019 | 32 | 0.380 |
Why?
| | Japan | 6 | 2021 | 115 | 0.370 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2024 | 446 | 0.360 |
Why?
| | Cells, Cultured | 12 | 2019 | 4193 | 0.350 |
Why?
| | Cisplatin | 3 | 2020 | 320 | 0.350 |
Why?
| | Pharmacovigilance | 2 | 2021 | 23 | 0.340 |
Why?
| | Transcription Factors | 6 | 2006 | 1719 | 0.340 |
Why?
| | Gene Expression Regulation | 7 | 2020 | 2607 | 0.330 |
Why?
| | Fatty Liver | 3 | 2012 | 243 | 0.330 |
Why?
| | DNA-Binding Proteins | 7 | 2008 | 1502 | 0.310 |
Why?
| | Acute Kidney Injury | 3 | 2025 | 815 | 0.310 |
Why?
| | Humans | 47 | 2025 | 137585 | 0.310 |
Why?
| | Phosphorylation | 9 | 2018 | 1759 | 0.300 |
Why?
| | Fukushima Nuclear Accident | 2 | 2020 | 2 | 0.300 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 9 | 2011 | 57 | 0.300 |
Why?
| | Male | 41 | 2025 | 67762 | 0.290 |
Why?
| | Inflammation | 6 | 2021 | 2837 | 0.290 |
Why?
| | Mice, Transgenic | 7 | 2018 | 2167 | 0.290 |
Why?
| | Protein Isoforms | 5 | 2019 | 404 | 0.290 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1242 | 0.290 |
Why?
| | Cardiovascular Diseases | 2 | 2018 | 2111 | 0.290 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 2 | 2024 | 262 | 0.280 |
Why?
| | Orphan Nuclear Receptors | 5 | 2012 | 15 | 0.280 |
Why?
| | Adiposity | 3 | 2010 | 518 | 0.280 |
Why?
| | Oleic Acid | 4 | 2009 | 40 | 0.280 |
Why?
| | Macrophages | 6 | 2021 | 1547 | 0.270 |
Why?
| | Mice, Inbred DBA | 2 | 2018 | 200 | 0.270 |
Why?
| | Cell Proliferation | 4 | 2024 | 2475 | 0.260 |
Why?
| | Myocardium | 4 | 2010 | 1002 | 0.260 |
Why?
| | AMP-Activated Protein Kinases | 5 | 2022 | 197 | 0.260 |
Why?
| | Receptors, LDL | 2 | 2018 | 47 | 0.240 |
Why?
| | Transcription, Genetic | 4 | 2020 | 1457 | 0.240 |
Why?
| | Obesity | 8 | 2010 | 2992 | 0.240 |
Why?
| | Insulin Resistance | 3 | 2009 | 1208 | 0.240 |
Why?
| | Fructokinases | 2 | 2016 | 32 | 0.240 |
Why?
| | Epithelial Cells | 4 | 2019 | 1096 | 0.230 |
Why?
| | Lymphoid Tissue | 1 | 2025 | 75 | 0.230 |
Why?
| | Tetraspanins | 2 | 2014 | 19 | 0.230 |
Why?
| | Uric Acid | 2 | 2024 | 163 | 0.220 |
Why?
| | Salmonella Infections | 1 | 2025 | 57 | 0.220 |
Why?
| | Deoxyglucose | 1 | 2024 | 53 | 0.220 |
Why?
| | Adipose Tissue | 4 | 2010 | 635 | 0.220 |
Why?
| | Urate Oxidase | 1 | 2024 | 11 | 0.220 |
Why?
| | Glomerulonephritis | 2 | 2021 | 47 | 0.210 |
Why?
| | Cell Line | 5 | 2018 | 2847 | 0.210 |
Why?
| | Energy Metabolism | 3 | 2008 | 922 | 0.210 |
Why?
| | Diet | 4 | 2021 | 1278 | 0.210 |
Why?
| | Fructose | 1 | 2004 | 112 | 0.210 |
Why?
| | Fibroblasts | 2 | 2021 | 996 | 0.210 |
Why?
| | Salmonella typhimurium | 1 | 2025 | 183 | 0.210 |
Why?
| | Liver X Receptors | 5 | 2012 | 31 | 0.200 |
Why?
| | Sebaceous Glands | 1 | 2002 | 5 | 0.200 |
Why?
| | Kidney Tubules, Proximal | 2 | 2022 | 128 | 0.200 |
Why?
| | Fatty Acids, Unsaturated | 4 | 2005 | 99 | 0.200 |
Why?
| | Gene Expression Regulation, Enzymologic | 3 | 2012 | 283 | 0.190 |
Why?
| | Isothiocyanates | 1 | 2022 | 2 | 0.190 |
Why?
| | Autophagy-Related Protein-1 Homolog | 1 | 2022 | 7 | 0.190 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2022 | 9 | 0.190 |
Why?
| | Lysosomes | 2 | 2021 | 141 | 0.190 |
Why?
| | Integrin alpha5 | 1 | 2021 | 2 | 0.190 |
Why?
| | Biomarkers | 5 | 2025 | 4149 | 0.190 |
Why?
| | Folate Receptor 2 | 1 | 2021 | 9 | 0.180 |
Why?
| | Judgment | 1 | 2022 | 60 | 0.180 |
Why?
| | Calibration | 1 | 2022 | 146 | 0.180 |
Why?
| | Multienzyme Complexes | 4 | 2005 | 68 | 0.180 |
Why?
| | Parathyroid Hormone | 1 | 2022 | 108 | 0.180 |
Why?
| | Dyslipidemias | 2 | 2022 | 176 | 0.180 |
Why?
| | Phosphates | 1 | 2022 | 182 | 0.180 |
Why?
| | Chernobyl Nuclear Accident | 1 | 2020 | 4 | 0.180 |
Why?
| | Toxins, Biological | 1 | 2020 | 12 | 0.170 |
Why?
| | Fibroblast Growth Factors | 1 | 2022 | 172 | 0.170 |
Why?
| | Kidney Glomerulus | 2 | 2019 | 119 | 0.170 |
Why?
| | Spectrum Analysis, Raman | 2 | 2011 | 41 | 0.170 |
Why?
| | Anticholesteremic Agents | 2 | 2012 | 153 | 0.170 |
Why?
| | Skin | 1 | 2005 | 752 | 0.170 |
Why?
| | Podocytes | 2 | 2019 | 69 | 0.170 |
Why?
| | Homeostasis | 2 | 2021 | 621 | 0.170 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2020 | 9 | 0.170 |
Why?
| | Amino Acid Sequence | 3 | 2019 | 2139 | 0.170 |
Why?
| | Tissue Distribution | 3 | 2007 | 332 | 0.160 |
Why?
| | Stomach Neoplasms | 1 | 2021 | 122 | 0.160 |
Why?
| | NF-kappa B | 1 | 2024 | 691 | 0.160 |
Why?
| | Bayes Theorem | 1 | 2022 | 405 | 0.160 |
Why?
| | Gene Knockout Techniques | 2 | 2018 | 118 | 0.160 |
Why?
| | Cattle | 3 | 2011 | 984 | 0.160 |
Why?
| | Down-Regulation | 4 | 2008 | 657 | 0.160 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2020 | 134 | 0.160 |
Why?
| | Insulin | 7 | 2009 | 2409 | 0.160 |
Why?
| | Hepatocytes | 2 | 2019 | 220 | 0.160 |
Why?
| | Kidney Failure, Chronic | 1 | 2025 | 570 | 0.150 |
Why?
| | HeLa Cells | 5 | 2025 | 636 | 0.150 |
Why?
| | Tretinoin | 1 | 2020 | 123 | 0.150 |
Why?
| | Fatty Acids, Monounsaturated | 4 | 2009 | 54 | 0.150 |
Why?
| | Blotting, Northern | 6 | 2005 | 201 | 0.150 |
Why?
| | Amino Acids | 2 | 2021 | 497 | 0.150 |
Why?
| | Mitochondria, Liver | 2 | 2012 | 73 | 0.150 |
Why?
| | Heat-Shock Response | 1 | 2019 | 77 | 0.150 |
Why?
| | Bacterial Proteins | 1 | 2025 | 879 | 0.150 |
Why?
| | Intestine, Small | 1 | 2020 | 156 | 0.150 |
Why?
| | Sepsis | 1 | 2025 | 617 | 0.150 |
Why?
| | Renal Insufficiency | 1 | 2021 | 162 | 0.150 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2022 | 279 | 0.150 |
Why?
| | Receptors, Fc | 1 | 2019 | 53 | 0.150 |
Why?
| | Osteopontin | 1 | 2018 | 33 | 0.140 |
Why?
| | Serum Albumin | 1 | 2019 | 150 | 0.140 |
Why?
| | Carrier Proteins | 2 | 2021 | 771 | 0.140 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2018 | 72 | 0.140 |
Why?
| | TRPP Cation Channels | 3 | 2024 | 85 | 0.140 |
Why?
| | Rats | 6 | 2024 | 5647 | 0.140 |
Why?
| | Fever | 1 | 2019 | 306 | 0.140 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2019 | 137 | 0.140 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2020 | 250 | 0.140 |
Why?
| | Quality Assurance, Health Care | 1 | 2020 | 322 | 0.140 |
Why?
| | Dietary Carbohydrates | 3 | 2007 | 155 | 0.140 |
Why?
| | Interleukin-33 | 1 | 2017 | 50 | 0.140 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2019 | 203 | 0.140 |
Why?
| | Databases, Factual | 2 | 2020 | 1357 | 0.140 |
Why?
| | Adaptive Immunity | 1 | 2018 | 165 | 0.140 |
Why?
| | Disease Progression | 3 | 2021 | 2757 | 0.140 |
Why?
| | Gene Knockdown Techniques | 3 | 2014 | 327 | 0.130 |
Why?
| | Chelating Agents | 1 | 2017 | 75 | 0.130 |
Why?
| | Ion Pumps | 1 | 2016 | 1 | 0.130 |
Why?
| | Phosphorus | 1 | 2017 | 97 | 0.130 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2017 | 66 | 0.130 |
Why?
| | Hypertriglyceridemia | 3 | 2008 | 39 | 0.130 |
Why?
| | Mice, Mutant Strains | 4 | 2012 | 298 | 0.130 |
Why?
| | Protein Structure, Tertiary | 3 | 2011 | 861 | 0.130 |
Why?
| | Female | 25 | 2025 | 73304 | 0.130 |
Why?
| | Adipocytes, White | 2 | 2022 | 19 | 0.130 |
Why?
| | Heart | 4 | 2010 | 655 | 0.130 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 430 | 0.120 |
Why?
| | Base Sequence | 4 | 2007 | 2181 | 0.120 |
Why?
| | Cell Differentiation | 4 | 2012 | 1991 | 0.120 |
Why?
| | Muscle, Smooth | 1 | 2016 | 155 | 0.120 |
Why?
| | Diet, Fat-Restricted | 2 | 2006 | 79 | 0.120 |
Why?
| | Carbohydrate Metabolism | 2 | 2007 | 59 | 0.120 |
Why?
| | Mitochondria | 3 | 2019 | 948 | 0.120 |
Why?
| | Radiation Monitoring | 1 | 2015 | 12 | 0.120 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 433 | 0.120 |
Why?
| | Nitric Oxide Synthase Type III | 2 | 2016 | 204 | 0.120 |
Why?
| | Radiometry | 1 | 2015 | 50 | 0.120 |
Why?
| | Albuminuria | 1 | 2016 | 185 | 0.120 |
Why?
| | Gene Expression Profiling | 4 | 2019 | 1774 | 0.120 |
Why?
| | Gamma Rays | 1 | 2015 | 57 | 0.120 |
Why?
| | Promoter Regions, Genetic | 1 | 2020 | 1250 | 0.120 |
Why?
| | Hydrocarbons, Fluorinated | 2 | 2012 | 9 | 0.120 |
Why?
| | Cell Cycle Proteins | 1 | 2019 | 617 | 0.120 |
Why?
| | Protein Binding | 3 | 2018 | 2224 | 0.110 |
Why?
| | Lung Neoplasms | 3 | 2020 | 2526 | 0.110 |
Why?
| | Metabolic Syndrome | 3 | 2008 | 354 | 0.110 |
Why?
| | Ketocholesterols | 1 | 2014 | 7 | 0.110 |
Why?
| | Bone Marrow | 1 | 2016 | 286 | 0.110 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2014 | 49 | 0.110 |
Why?
| | Osteoblasts | 2 | 2012 | 126 | 0.110 |
Why?
| | Immunoglobulin G | 1 | 2019 | 893 | 0.110 |
Why?
| | Ezetimibe | 1 | 2014 | 24 | 0.110 |
Why?
| | Azetidines | 1 | 2014 | 43 | 0.110 |
Why?
| | Simvastatin | 1 | 2014 | 61 | 0.110 |
Why?
| | DNA Damage | 1 | 2017 | 420 | 0.110 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 916 | 0.110 |
Why?
| | Body Weight | 7 | 2010 | 985 | 0.100 |
Why?
| | Dehydration | 1 | 2013 | 51 | 0.100 |
Why?
| | Bone Density | 1 | 2017 | 489 | 0.100 |
Why?
| | Sensitivity and Specificity | 1 | 2018 | 1946 | 0.100 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 697 | 0.100 |
Why?
| | Hypertension | 1 | 2022 | 1295 | 0.100 |
Why?
| | Cholesterol Ester Transfer Proteins | 1 | 2012 | 20 | 0.100 |
Why?
| | Benzoates | 1 | 2012 | 43 | 0.100 |
Why?
| | Middle Aged | 7 | 2025 | 33479 | 0.100 |
Why?
| | Muscle, Skeletal | 5 | 2005 | 1724 | 0.100 |
Why?
| | Catechin | 1 | 2012 | 24 | 0.100 |
Why?
| | Isoxazoles | 1 | 2012 | 54 | 0.100 |
Why?
| | Nicorandil | 1 | 2012 | 11 | 0.100 |
Why?
| | Lipoproteins, HDL | 1 | 2012 | 77 | 0.100 |
Why?
| | Nitric Oxide Donors | 1 | 2012 | 21 | 0.090 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2018 | 900 | 0.090 |
Why?
| | Minerals | 1 | 2012 | 42 | 0.090 |
Why?
| | DNA Primers | 3 | 2007 | 515 | 0.090 |
Why?
| | Case-Control Studies | 3 | 2017 | 3556 | 0.090 |
Why?
| | Mitochondrial Diseases | 1 | 2012 | 91 | 0.090 |
Why?
| | Oxidation-Reduction | 5 | 2010 | 1060 | 0.090 |
Why?
| | Biomedical Research | 1 | 2018 | 692 | 0.090 |
Why?
| | RNA, Messenger | 7 | 2018 | 2833 | 0.090 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2011 | 33 | 0.090 |
Why?
| | Antioxidants | 2 | 2012 | 584 | 0.090 |
Why?
| | Molecular Imaging | 1 | 2011 | 56 | 0.090 |
Why?
| | Mice, Nude | 3 | 2021 | 698 | 0.090 |
Why?
| | Drug Therapy, Combination | 1 | 2014 | 1066 | 0.090 |
Why?
| | Aorta | 2 | 2012 | 417 | 0.090 |
Why?
| | Models, Biological | 5 | 2006 | 1783 | 0.090 |
Why?
| | Sulfonamides | 2 | 2012 | 513 | 0.090 |
Why?
| | Glucose | 2 | 2007 | 1020 | 0.090 |
Why?
| | Etoposide | 1 | 2011 | 158 | 0.090 |
Why?
| | Plaque, Atherosclerotic | 1 | 2011 | 57 | 0.090 |
Why?
| | Risk Factors | 3 | 2022 | 10388 | 0.090 |
Why?
| | Alkaline Phosphatase | 1 | 2011 | 148 | 0.080 |
Why?
| | Chenodeoxycholic Acid | 1 | 2010 | 16 | 0.080 |
Why?
| | Cholesterol, HDL | 2 | 2012 | 203 | 0.080 |
Why?
| | Nerve Tissue Proteins | 1 | 2014 | 596 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2018 | 3284 | 0.080 |
Why?
| | Antineoplastic Agents | 2 | 2020 | 2129 | 0.080 |
Why?
| | Mice, Obese | 3 | 2006 | 66 | 0.080 |
Why?
| | Aged | 5 | 2025 | 23961 | 0.080 |
Why?
| | Diacylglycerol O-Acyltransferase | 2 | 2006 | 5 | 0.080 |
Why?
| | Aging | 2 | 2019 | 1864 | 0.080 |
Why?
| | Cell Movement | 1 | 2014 | 967 | 0.080 |
Why?
| | Agouti Signaling Protein | 1 | 2009 | 3 | 0.080 |
Why?
| | Cholic Acids | 1 | 2008 | 18 | 0.080 |
Why?
| | Gene Silencing | 2 | 2016 | 195 | 0.070 |
Why?
| | Hypercholesterolemia | 2 | 2006 | 106 | 0.070 |
Why?
| | Microscopy | 1 | 2010 | 152 | 0.070 |
Why?
| | Hyperlipidemia, Familial Combined | 1 | 2008 | 3 | 0.070 |
Why?
| | Mutation | 6 | 2018 | 3958 | 0.070 |
Why?
| | Ceramides | 2 | 2010 | 118 | 0.070 |
Why?
| | Diabetic Nephropathies | 1 | 2012 | 294 | 0.070 |
Why?
| | Transgenes | 2 | 2006 | 180 | 0.070 |
Why?
| | Phosphatidylcholines | 2 | 2008 | 147 | 0.070 |
Why?
| | Receptor, Insulin | 2 | 2006 | 105 | 0.070 |
Why?
| | Lipocalin-2 | 2 | 2020 | 79 | 0.070 |
Why?
| | Blotting, Western | 6 | 2007 | 1226 | 0.070 |
Why?
| | Acyltransferases | 2 | 2005 | 57 | 0.070 |
Why?
| | Microsomes | 2 | 2007 | 33 | 0.070 |
Why?
| | Glycogen | 2 | 2004 | 55 | 0.070 |
Why?
| | Mycological Typing Techniques | 1 | 2007 | 1 | 0.070 |
Why?
| | Tumor Burden | 2 | 2020 | 309 | 0.070 |
Why?
| | Time Factors | 4 | 2019 | 6828 | 0.070 |
Why?
| | Gluconeogenesis | 1 | 2007 | 79 | 0.070 |
Why?
| | Histoplasma | 1 | 2007 | 12 | 0.070 |
Why?
| | Glucose Tolerance Test | 1 | 2009 | 366 | 0.070 |
Why?
| | Histoplasmosis | 1 | 2007 | 17 | 0.070 |
Why?
| | Adipose Tissue, Brown | 2 | 2004 | 53 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2531 | 0.070 |
Why?
| | Animal Feed | 2 | 2004 | 53 | 0.070 |
Why?
| | Sucrose | 1 | 2007 | 110 | 0.070 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2017 | 528 | 0.070 |
Why?
| | Pedigree | 1 | 2008 | 514 | 0.070 |
Why?
| | Health Surveys | 2 | 2021 | 514 | 0.060 |
Why?
| | Mice, SCID | 2 | 2004 | 367 | 0.060 |
Why?
| | Blood Pressure | 4 | 2016 | 1786 | 0.060 |
Why?
| | Child | 3 | 2021 | 21935 | 0.060 |
Why?
| | Lipolysis | 2 | 2022 | 46 | 0.060 |
Why?
| | Autophagy-Related Protein 7 | 1 | 2025 | 13 | 0.060 |
Why?
| | Choline-Phosphate Cytidylyltransferase | 1 | 2005 | 3 | 0.060 |
Why?
| | Regulatory-Associated Protein of mTOR | 1 | 2025 | 24 | 0.060 |
Why?
| | Molecular Sequence Data | 3 | 2006 | 2900 | 0.060 |
Why?
| | Carnitine O-Palmitoyltransferase | 4 | 2007 | 46 | 0.060 |
Why?
| | Colitis | 1 | 2008 | 266 | 0.060 |
Why?
| | Receptors, Retinoic Acid | 2 | 2020 | 43 | 0.060 |
Why?
| | Palmitoyl Coenzyme A | 1 | 2004 | 2 | 0.060 |
Why?
| | Oxypurinol | 1 | 2024 | 3 | 0.060 |
Why?
| | Oxonic Acid | 1 | 2024 | 5 | 0.060 |
Why?
| | Structure-Activity Relationship | 2 | 2018 | 570 | 0.060 |
Why?
| | Up-Regulation | 2 | 2004 | 843 | 0.060 |
Why?
| | Lipodystrophy | 1 | 2004 | 13 | 0.050 |
Why?
| | Thermogenesis | 1 | 2004 | 44 | 0.050 |
Why?
| | Hypothermia | 1 | 2004 | 36 | 0.050 |
Why?
| | Linoleic Acid | 1 | 2004 | 43 | 0.050 |
Why?
| | Xanthine Oxidase | 1 | 2024 | 81 | 0.050 |
Why?
| | Chronic Disease | 1 | 2010 | 1793 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2012 | 2828 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2024 | 2486 | 0.050 |
Why?
| | Cholestasis | 1 | 2006 | 235 | 0.050 |
Why?
| | Animal Nutritional Physiological Phenomena | 1 | 2003 | 14 | 0.050 |
Why?
| | Anti-Obesity Agents | 1 | 2004 | 57 | 0.050 |
Why?
| | Transfection | 2 | 2021 | 945 | 0.050 |
Why?
| | Body Temperature Regulation | 1 | 2004 | 97 | 0.050 |
Why?
| | Culture Media, Conditioned | 2 | 2016 | 110 | 0.050 |
Why?
| | Foam Cells | 2 | 2016 | 18 | 0.050 |
Why?
| | Cell Membrane | 2 | 2005 | 738 | 0.050 |
Why?
| | Animals, Newborn | 1 | 2005 | 844 | 0.050 |
Why?
| | Chromatography, Gas | 1 | 2002 | 33 | 0.050 |
Why?
| | Cold Temperature | 1 | 2004 | 179 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2003 | 272 | 0.050 |
Why?
| | Cholesterol, Dietary | 1 | 2002 | 18 | 0.050 |
Why?
| | Inflammasomes | 1 | 2024 | 131 | 0.050 |
Why?
| | Neoplasm Invasiveness | 2 | 2014 | 510 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2003 | 385 | 0.050 |
Why?
| | Sulfoxides | 1 | 2022 | 3 | 0.050 |
Why?
| | Cytokines | 2 | 2024 | 2085 | 0.050 |
Why?
| | Thiazolidines | 1 | 2022 | 9 | 0.050 |
Why?
| | 3T3-L1 Cells | 1 | 2022 | 36 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2003 | 172 | 0.050 |
Why?
| | Dehydroepiandrosterone | 1 | 2002 | 51 | 0.050 |
Why?
| | Protein Transport | 2 | 2019 | 445 | 0.050 |
Why?
| | Muscle Proteins | 1 | 2003 | 231 | 0.050 |
Why?
| | Aminopterin | 1 | 2021 | 2 | 0.050 |
Why?
| | Host-Pathogen Interactions | 1 | 2025 | 364 | 0.050 |
Why?
| | Hypolipidemic Agents | 1 | 2022 | 91 | 0.050 |
Why?
| | RNA | 2 | 2007 | 921 | 0.050 |
Why?
| | Apoptosis | 3 | 2020 | 2553 | 0.040 |
Why?
| | Phospholipids | 1 | 2003 | 223 | 0.040 |
Why?
| | Saccharomyces cerevisiae | 1 | 2006 | 557 | 0.040 |
Why?
| | Autophagosomes | 1 | 2021 | 19 | 0.040 |
Why?
| | Social Conditions | 1 | 2020 | 12 | 0.040 |
Why?
| | Norway | 1 | 2020 | 43 | 0.040 |
Why?
| | Enzyme Activation | 3 | 2011 | 810 | 0.040 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 46 | 0.040 |
Why?
| | Proteinuria | 1 | 2021 | 97 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5472 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2024 | 840 | 0.040 |
Why?
| | Biological Assay | 1 | 2021 | 124 | 0.040 |
Why?
| | Models, Genetic | 1 | 2003 | 600 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2005 | 860 | 0.040 |
Why?
| | Hypophosphatemia, Familial | 1 | 2020 | 4 | 0.040 |
Why?
| | Adipocytes | 1 | 2002 | 222 | 0.040 |
Why?
| | Blood Urea Nitrogen | 1 | 2020 | 54 | 0.040 |
Why?
| | Butadienes | 1 | 2020 | 36 | 0.040 |
Why?
| | Folic Acid | 1 | 2021 | 186 | 0.040 |
Why?
| | Retinoid X Receptors | 1 | 2020 | 39 | 0.040 |
Why?
| | Methotrexate | 1 | 2021 | 260 | 0.040 |
Why?
| | Drug Prescriptions | 1 | 2022 | 245 | 0.040 |
Why?
| | Immunoblotting | 3 | 2005 | 308 | 0.040 |
Why?
| | 2,4-Dinitrophenol | 1 | 2019 | 9 | 0.040 |
Why?
| | NIH 3T3 Cells | 1 | 2020 | 144 | 0.040 |
Why?
| | Vegetables | 1 | 2021 | 157 | 0.040 |
Why?
| | Kidney Medulla | 1 | 2019 | 35 | 0.040 |
Why?
| | Oxygen | 1 | 2004 | 931 | 0.040 |
Why?
| | Pyrimidinones | 1 | 2020 | 113 | 0.040 |
Why?
| | Reactive Oxygen Species | 2 | 2012 | 622 | 0.040 |
Why?
| | Nitriles | 1 | 2020 | 172 | 0.040 |
Why?
| | Liver Regeneration | 1 | 2019 | 46 | 0.040 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2019 | 73 | 0.040 |
Why?
| | Cell Self Renewal | 1 | 2019 | 56 | 0.040 |
Why?
| | Testosterone | 1 | 2002 | 409 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2020 | 455 | 0.040 |
Why?
| | Fibrosis | 1 | 2021 | 552 | 0.040 |
Why?
| | DNA | 1 | 2005 | 1459 | 0.040 |
Why?
| | Pyridones | 1 | 2020 | 168 | 0.040 |
Why?
| | Adult | 5 | 2022 | 37929 | 0.040 |
Why?
| | Odds Ratio | 1 | 2021 | 1070 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2020 | 320 | 0.040 |
Why?
| | Urinary Tract | 1 | 2018 | 51 | 0.030 |
Why?
| | Stem Cells | 1 | 2002 | 594 | 0.030 |
Why?
| | In Vitro Techniques | 2 | 2012 | 1092 | 0.030 |
Why?
| | Glomerular Filtration Rate | 1 | 2021 | 746 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 434 | 0.030 |
Why?
| | Weight Loss | 1 | 2002 | 787 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2014 | 3412 | 0.030 |
Why?
| | Mice, Knockout, ApoE | 1 | 2016 | 11 | 0.030 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2018 | 190 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 313 | 0.030 |
Why?
| | Dietary Fats, Unsaturated | 2 | 2006 | 23 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2021 | 7635 | 0.030 |
Why?
| | RAW 264.7 Cells | 1 | 2016 | 50 | 0.030 |
Why?
| | Nuclear Power Plants | 1 | 2015 | 3 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2021 | 5778 | 0.030 |
Why?
| | Health Status | 1 | 2020 | 792 | 0.030 |
Why?
| | Oxidative Stress | 2 | 2012 | 1317 | 0.030 |
Why?
| | Pyridines | 1 | 2019 | 506 | 0.030 |
Why?
| | Hyperlipidemias | 1 | 2016 | 120 | 0.030 |
Why?
| | Chemokine CXCL6 | 1 | 2014 | 2 | 0.030 |
Why?
| | Mice, Inbred Strains | 2 | 2006 | 409 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2016 | 316 | 0.030 |
Why?
| | Hematopoiesis | 1 | 2016 | 192 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2017 | 366 | 0.030 |
Why?
| | History, 21st Century | 1 | 2015 | 213 | 0.030 |
Why?
| | Cohort Studies | 1 | 2025 | 5742 | 0.030 |
Why?
| | Blood Glucose | 4 | 2006 | 2186 | 0.030 |
Why?
| | Gene Expression | 3 | 2004 | 1502 | 0.030 |
Why?
| | Creatinine | 1 | 2016 | 499 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 2017 | 491 | 0.030 |
Why?
| | Fatty Acid Synthases | 2 | 2005 | 24 | 0.030 |
Why?
| | Kidney Cortex | 1 | 2013 | 26 | 0.030 |
Why?
| | Aldehyde Reductase | 1 | 2013 | 29 | 0.030 |
Why?
| | Radiation Dosage | 1 | 2015 | 179 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2804 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2057 | 0.030 |
Why?
| | Hyaluronan Receptors | 1 | 2014 | 102 | 0.030 |
Why?
| | Immunotherapy | 1 | 2018 | 641 | 0.030 |
Why?
| | ras Proteins | 1 | 2014 | 153 | 0.030 |
Why?
| | Lipoproteins, VLDL | 2 | 2002 | 18 | 0.020 |
Why?
| | Hypoglycemic Agents | 1 | 2022 | 1291 | 0.020 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 267 | 0.020 |
Why?
| | Macaca fascicularis | 1 | 2012 | 65 | 0.020 |
Why?
| | Cytochromes c | 1 | 2012 | 60 | 0.020 |
Why?
| | Pregnancy | 1 | 2005 | 6763 | 0.020 |
Why?
| | beta Catenin | 1 | 2014 | 253 | 0.020 |
Why?
| | Succinate Dehydrogenase | 1 | 2012 | 50 | 0.020 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2014 | 209 | 0.020 |
Why?
| | Streptozocin | 1 | 2012 | 21 | 0.020 |
Why?
| | Cholesterol Esters | 1 | 2011 | 8 | 0.020 |
Why?
| | Cardiac Surgical Procedures | 1 | 2017 | 530 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2014 | 1272 | 0.020 |
Why?
| | Bone Matrix | 1 | 2011 | 5 | 0.020 |
Why?
| | Calcification, Physiologic | 1 | 2011 | 32 | 0.020 |
Why?
| | Young Adult | 2 | 2020 | 13209 | 0.020 |
Why?
| | Biological Transport | 1 | 2012 | 418 | 0.020 |
Why?
| | Serum | 1 | 2011 | 59 | 0.020 |
Why?
| | Species Specificity | 1 | 2012 | 585 | 0.020 |
Why?
| | Molecular Structure | 1 | 2012 | 489 | 0.020 |
Why?
| | Gene Deletion | 1 | 2012 | 391 | 0.020 |
Why?
| | Diet, High-Fat | 1 | 2012 | 247 | 0.020 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 136 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 1 | 2014 | 648 | 0.020 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2012 | 195 | 0.020 |
Why?
| | Flow Cytometry | 2 | 2006 | 1178 | 0.020 |
Why?
| | Epididymis | 1 | 2010 | 12 | 0.020 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2010 | 173 | 0.020 |
Why?
| | Macrophages, Peritoneal | 1 | 2009 | 94 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2010 | 168 | 0.020 |
Why?
| | Stromal Cells | 1 | 2009 | 112 | 0.020 |
Why?
| | Paracrine Communication | 1 | 2009 | 65 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 976 | 0.020 |
Why?
| | Feces | 1 | 2012 | 484 | 0.020 |
Why?
| | Oxygen Consumption | 2 | 2002 | 696 | 0.020 |
Why?
| | Caspase 3 | 1 | 2010 | 246 | 0.020 |
Why?
| | ATP Binding Cassette Transporter 1 | 1 | 2008 | 10 | 0.020 |
Why?
| | Adolescent | 2 | 2020 | 21513 | 0.020 |
Why?
| | Hepatocyte Nuclear Factor 4 | 1 | 2008 | 15 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 466 | 0.020 |
Why?
| | Palmitates | 1 | 2007 | 18 | 0.020 |
Why?
| | Dextran Sulfate | 1 | 2008 | 83 | 0.020 |
Why?
| | PPAR alpha | 1 | 2007 | 58 | 0.020 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2008 | 137 | 0.020 |
Why?
| | Sporothrix | 1 | 2007 | 3 | 0.020 |
Why?
| | Paracoccidioides | 1 | 2007 | 2 | 0.020 |
Why?
| | Pigments, Biological | 1 | 2007 | 16 | 0.020 |
Why?
| | DNA Fingerprinting | 1 | 2007 | 26 | 0.020 |
Why?
| | Blastomyces | 1 | 2007 | 9 | 0.020 |
Why?
| | Collagen | 1 | 2010 | 452 | 0.020 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2007 | 68 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2008 | 268 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2025 | 15657 | 0.020 |
Why?
| | DNA, Fungal | 1 | 2007 | 80 | 0.020 |
Why?
| | Lipid Metabolism Disorders | 1 | 2006 | 3 | 0.020 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2007 | 132 | 0.020 |
Why?
| | Liver Glycogen | 1 | 2006 | 17 | 0.020 |
Why?
| | PPAR gamma | 1 | 2008 | 182 | 0.020 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2006 | 42 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2008 | 523 | 0.020 |
Why?
| | Receptors, Leptin | 1 | 2006 | 23 | 0.020 |
Why?
| | Ventricular Function, Left | 1 | 2010 | 534 | 0.020 |
Why?
| | Receptors, Steroid | 1 | 2006 | 50 | 0.020 |
Why?
| | Haplotypes | 1 | 2008 | 494 | 0.020 |
Why?
| | Mitochondrial Membranes | 1 | 2006 | 39 | 0.020 |
Why?
| | Lipoproteins, LDL | 1 | 2006 | 116 | 0.020 |
Why?
| | Response Elements | 1 | 2006 | 91 | 0.020 |
Why?
| | Octoxynol | 1 | 2005 | 13 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2006 | 155 | 0.020 |
Why?
| | Endopeptidase K | 1 | 2005 | 17 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2006 | 183 | 0.020 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2005 | 51 | 0.020 |
Why?
| | Oligonucleotides, Antisense | 1 | 2006 | 112 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2010 | 528 | 0.020 |
Why?
| | Acyl-CoA Oxidase | 1 | 2005 | 2 | 0.020 |
Why?
| | Ethanolaminephosphotransferase | 1 | 2005 | 1 | 0.010 |
Why?
| | Glycerol-3-Phosphate O-Acyltransferase | 1 | 2005 | 1 | 0.010 |
Why?
| | Microarray Analysis | 1 | 2005 | 117 | 0.010 |
Why?
| | Fish Oils | 1 | 2005 | 26 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2006 | 325 | 0.010 |
Why?
| | Thinness | 1 | 2005 | 91 | 0.010 |
Why?
| | Serine C-Palmitoyltransferase | 1 | 2004 | 8 | 0.010 |
Why?
| | Serine | 1 | 2005 | 141 | 0.010 |
Why?
| | Acyl Coenzyme A | 1 | 2004 | 31 | 0.010 |
Why?
| | Sphingomyelins | 1 | 2004 | 33 | 0.010 |
Why?
| | Muscle Fibers, Fast-Twitch | 1 | 2004 | 17 | 0.010 |
Why?
| | Glycerol | 1 | 2005 | 94 | 0.010 |
Why?
| | Palmitic Acid | 1 | 2004 | 41 | 0.010 |
Why?
| | Catalysis | 1 | 2005 | 307 | 0.010 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2006 | 177 | 0.010 |
Why?
| | Receptors, Adrenergic, beta-3 | 1 | 2004 | 4 | 0.010 |
Why?
| | Homozygote | 1 | 2005 | 203 | 0.010 |
Why?
| | Echocardiography | 1 | 2007 | 642 | 0.010 |
Why?
| | Uncoupling Protein 1 | 1 | 2004 | 16 | 0.010 |
Why?
| | Protein Structure, Secondary | 1 | 2005 | 374 | 0.010 |
Why?
| | Plasmids | 1 | 2005 | 363 | 0.010 |
Why?
| | Cysteine | 1 | 2005 | 204 | 0.010 |
Why?
| | Fats | 1 | 2004 | 17 | 0.010 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2004 | 17 | 0.010 |
Why?
| | Trans-Activators | 1 | 2006 | 398 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2009 | 785 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 402 | 0.010 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2004 | 159 | 0.010 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2005 | 218 | 0.010 |
Why?
| | Ion Channels | 1 | 2004 | 133 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2015 | 6079 | 0.010 |
Why?
| | Protein Subunits | 1 | 2004 | 239 | 0.010 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2003 | 51 | 0.010 |
Why?
| | Glucose Transporter Type 4 | 1 | 2003 | 40 | 0.010 |
Why?
| | Epitopes | 1 | 2005 | 479 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2006 | 665 | 0.010 |
Why?
| | Body Temperature | 1 | 2004 | 222 | 0.010 |
Why?
| | Energy Intake | 1 | 2006 | 485 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2006 | 1062 | 0.010 |
Why?
| | Muscles | 1 | 2004 | 326 | 0.010 |
Why?
| | Hydroxymethylglutaryl CoA Reductases | 1 | 2002 | 14 | 0.010 |
Why?
| | Protein Conformation | 1 | 2005 | 934 | 0.010 |
Why?
| | Vacuoles | 1 | 2002 | 40 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 2002 | 137 | 0.010 |
Why?
| | Microsomes, Liver | 1 | 2002 | 86 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2005 | 1353 | 0.010 |
Why?
| | Cell Size | 1 | 2002 | 91 | 0.010 |
Why?
| | 3T3 Cells | 1 | 2002 | 163 | 0.010 |
Why?
| | Gene Dosage | 1 | 2002 | 140 | 0.010 |
Why?
| | Mitochondrial Proteins | 1 | 2004 | 257 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2002 | 431 | 0.010 |
Why?
| | Infant | 1 | 2015 | 9465 | 0.010 |
Why?
| | Child, Preschool | 1 | 2015 | 11074 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2002 | 767 | 0.010 |
Why?
| | Phylogeny | 1 | 2004 | 904 | 0.010 |
Why?
| | Eating | 1 | 2002 | 380 | 0.010 |
Why?
| | Kinetics | 1 | 2002 | 1670 | 0.010 |
Why?
| | Body Mass Index | 1 | 2005 | 2389 | 0.010 |
Why?
|
|
Miyazaki's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|